Menu
GeneBe

rs200781310

Variant summary

Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2

The NM_016239.4(MYO15A):c.8708G>A(p.Arg2903Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000374 in 1,613,926 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00020 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00039 ( 0 hom. )

Consequence

MYO15A
NM_016239.4 missense

Scores

1
14

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:5B:1

Conservation

PhyloP100: 1.30
Variant links:
Genes affected
MYO15A (HGNC:7594): (myosin XVA) This gene encodes an unconventional myosin. This protein differs from other myosins in that it has a long N-terminal extension preceding the conserved motor domain. Studies in mice suggest that this protein is necessary for actin organization in the hair cells of the cochlea. Mutations in this gene have been associated with profound, congenital, neurosensory, nonsyndromal deafness. This gene is located within the Smith-Magenis syndrome region on chromosome 17. Read-through transcripts containing an upstream gene and this gene have been identified, but they are not thought to encode a fusion protein. Several alternatively spliced transcript variants have been described, but their full length sequences have not been determined. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
MYO15ANM_016239.4 linkuse as main transcriptc.8708G>A p.Arg2903Gln missense_variant 49/66 ENST00000647165.2
MYO15AXM_017024715.3 linkuse as main transcriptc.8711G>A p.Arg2904Gln missense_variant 47/64
MYO15AXM_017024714.3 linkuse as main transcriptc.8648G>A p.Arg2883Gln missense_variant 46/63

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
MYO15AENST00000647165.2 linkuse as main transcriptc.8708G>A p.Arg2903Gln missense_variant 49/66 NM_016239.4 P1Q9UKN7-1

Frequencies

GnomAD3 genomes
AF:
0.000197
AC:
30
AN:
152230
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000723
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000621
Gnomad FIN
AF:
0.000188
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000309
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000245
AC:
61
AN:
248826
Hom.:
0
AF XY:
0.000288
AC XY:
39
AN XY:
135254
show subpopulations
Gnomad AFR exome
AF:
0.0000649
Gnomad AMR exome
AF:
0.000116
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000327
Gnomad FIN exome
AF:
0.000186
Gnomad NFE exome
AF:
0.000373
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000393
AC:
574
AN:
1461696
Hom.:
0
Cov.:
32
AF XY:
0.000424
AC XY:
308
AN XY:
727160
show subpopulations
Gnomad4 AFR exome
AF:
0.0000597
Gnomad4 AMR exome
AF:
0.000179
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000371
Gnomad4 FIN exome
AF:
0.000150
Gnomad4 NFE exome
AF:
0.000461
Gnomad4 OTH exome
AF:
0.000182
GnomAD4 genome
AF:
0.000197
AC:
30
AN:
152230
Hom.:
0
Cov.:
33
AF XY:
0.000148
AC XY:
11
AN XY:
74376
show subpopulations
Gnomad4 AFR
AF:
0.0000723
Gnomad4 AMR
AF:
0.0000654
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000621
Gnomad4 FIN
AF:
0.000188
Gnomad4 NFE
AF:
0.000309
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000385
Hom.:
0
Bravo
AF:
0.000223
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000519
AC:
2
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000722
AC:
6
ExAC
AF:
0.000207
AC:
25
EpiCase
AF:
0.000491
EpiControl
AF:
0.000296

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:5Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:2Benign:1
Uncertain significance, criteria provided, single submitterclinical testingGeneDxJul 19, 2021In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 27535533) -
Likely benign, criteria provided, single submitterclinical testingInvitaeJan 22, 2024- -
Uncertain significance, criteria provided, single submitterclinical testingMayo Clinic Laboratories, Mayo ClinicOct 28, 2022BP4, PM2_supporting -
not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineSep 04, 2014Variant classified as Uncertain Significance - Favor Benign. The Arg2903Gln vari ant in MYO15A has not been previously reported in individuals with hearing loss, but has been identified in 0.07% (6/8308) of European American chromosomes by t he NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS/; dbSNP rs20 0781310). The arginine (Arg) residue at position 2903 is not fully conserved in mammals and across evolutionarily distant species, with one mammal (squirrel mon key) having glutamine (Gln) at this position, which raises the possibility that this change may be tolerated. Additional computational prediction tools do not p rovide strong support for or against an impact to the protein. In summary, while the clinical significance of the Arg2903Gln variant is uncertain, the frequency and conservation data suggest that it is more likely to be benign. -
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsNov 10, 2022The c.8708G>A (p.R2903Q) alteration is located in exon 49 (coding exon 48) of the MYO15A gene. This alteration results from a G to A substitution at nucleotide position 8708, causing the arginine (R) at amino acid position 2903 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Autosomal recessive nonsyndromic hearing loss 3 Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsFeb 03, 2022- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.077
BayesDel_addAF
Benign
-0.35
T
BayesDel_noAF
Benign
-0.42
Cadd
Benign
22
Dann
Benign
0.96
DEOGEN2
Benign
0.0057
T;T;T;.;.
Eigen
Benign
-0.64
Eigen_PC
Benign
-0.59
FATHMM_MKL
Benign
0.031
N
LIST_S2
Benign
0.70
T;.;T;T;T
M_CAP
Benign
0.080
D
MetaRNN
Benign
0.032
T;T;T;T;T
MetaSVM
Benign
-0.71
T
MutationTaster
Benign
1.0
N;N
PrimateAI
Benign
0.46
T
Sift4G
Uncertain
0.010
D;D;.;T;.
Polyphen
0.12
.;B;B;.;.
Vest4
0.18
MVP
0.73
ClinPred
0.029
T
GERP RS
2.8
Varity_R
0.031
gMVP
0.24

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.44
Details are displayed if max score is > 0.2
DS_DG_spliceai
0.44
Position offset: 1

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs200781310; hg19: chr17-18060374; API